Publications by authors named "A Steffanina"
Article Synopsis
- Obstructive sleep apnea (OSA) and obstructive lung diseases (OLD), such as COPD and asthma, are linked in a condition referred to as OLDOSA syndrome, where one disorder can worsen the other.
- The study involved 101 patients diagnosed with OSA and either asthma or COPD, assessing their lung function and sleep patterns using pulmonary function tests (PFTs) and nighttime monitoring.
- Findings suggest that those with overlap syndrome (OSA combined with COPD) experience more severe symptoms and a worse impact on breathing during sleep than those with alternative overlap syndrome (OSA combined with asthma), indicating a significant relationship between the two conditions.
Purpose: OSAS is a syndrome that often presents clinically differently between men and women. The aim of this study was to assess the clinical presentation, nocturnal home sleep cardiorespiratory monitoring and therapeutic adherence to CPAP in both sexes to identify the most frequent patterns.
Methods: Data from the first visit, the nocturnal home sleep cardiorespiratory monitoring and follow-up visit of 74 OSA patients were collected.
Sarcoidosis is a systemic granulomatous disorder of unknown etiology characterized by non-caseating granulomas at the site of disease. A confident diagnosis should be established by the evidence of typical granulomas on biopsy and after exclusion of other conditions. Clinically recognizable Gastrointestinal involvement (GI) occurs in less than 1.
View Article and Find Full Text PDFObjective: Resistant hypertension (RH) may be associated with Obstructive Sleep Apnea (OSA), determining a remarkable increase in cardiovascular risk. The aim of the study was to assess the effect of six months with continuous positive airway pressure (CPAP) treatment on blood pressure (BP) values, cardiovascular risk markers, and exercise tolerance in patients with RH and OSA.
Patients And Methods: Twenty-four patients with RH and OSA were recruited and 24-hour ambulatory BP, intima-media thickness (IMT), flow mediated dilation (FMD), renal resistive index (RRI), and endurance cardiopulmonary exercise testing (CPET) were obtained at enrollment and after 6-month treatment.